Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

FPHAF FARON PHARMACEUTICALS OY

Watchlist
3.3000.0000.00%
Close  02/03 16:00 ET
High
0.000
Open
3.300
Turnover
0.00
Low
0.000
Pre Close
3.300
Volume
0.00
Market Cap
209.54M
P/E(TTM)
Loss
52wk High
3.300
Shares
63.50M
P/E(Static)
Loss
52wk Low
3.100
Float Cap
209.54M
Bid/Ask %
0.00%
Historical High
6.000
Shs Float
63.50M
Volume Ratio
0.00
Historical Low
3.100
Dividend TTM
--
Div Yield TTM
--
P/B
56.90
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Float Cap
209.54M
Bid/Ask %
0.00%
Historical High
6.000
Shs Float
63.50M
Volume Ratio
0.00
Historical Low
3.100
Dividend TTM
--
P/B
56.90
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
1
Price Forecast

News

Comment

No More
Company Overview More
Faron Pharmaceuticals Oy operates as a clinical stage biopharmaceutical company. It develops novel treatments for medical conditions with significant unmet needs caused by dysfunction of immune system. The firm currently has a pipeline based on the receptors involved in regulation of immune response in oncology, organ damage and bone marrow regeneration. Its Bexmarilimab, a novel anti-Clever-1 humanized antibody, is its investigative precision immunotherapy with the potential to provide permanent immune stimulation for difficult-to-treat cancers through targeting myeloid function. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen in 2003 and is headquartered in Turku, Finland.
CEO: Dr. Markku Tapani Jalkanen
Market: Pink Market
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist